Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma

BACKGROUND: Elevated serum YKL-40 levels have been observed in various cancers. We evaluated the diagnostic performance of serum YKL-40 alone or in combination with the CEA, CYFRA21-1 and SCCA tumor markers for patients with esophageal squamous cell carcinoma (ESCC). METHODS: YKL-40 was detected in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xin, Xing, Shan, Liu, Xiao-Min, Liu, Wen, Liu, Dan, Chi, Pei-Dong, Chen, Hao, Dai, Shu-Qin, Zhong, Qian, Zeng, Mu-Sheng, Liu, Wan-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094903/
https://www.ncbi.nlm.nih.gov/pubmed/25001061
http://dx.doi.org/10.1186/1471-2407-14-490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094903/
https://www.ncbi.nlm.nih.gov/pubmed/25001061
http://dx.doi.org/10.1186/1471-2407-14-490

Ejemplares similares